Cardiac output during ritodrine treatment in premature labor
Unlike other β-mimetic drugs, ritodrine hydrochloride is able to inhibit uterine contractility in premature labor without producing hypotension. Based on previous studies, we have postulated that this homeostatic effect of ritodrine is caused by an increase in cardiac output. In 5 women in premature...
Gespeichert in:
Veröffentlicht in: | American journal of obstetrics and gynecology 1974-04, Vol.118 (7), p.910-920 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 920 |
---|---|
container_issue | 7 |
container_start_page | 910 |
container_title | American journal of obstetrics and gynecology |
container_volume | 118 |
creator | Bieniarz, Joseph Ivankovich, Anthony Scommegna, Antonio |
description | Unlike other β-mimetic drugs, ritodrine hydrochloride is able to inhibit uterine contractility in premature labor without producing hypotension. Based on previous studies, we have postulated that this homeostatic effect of ritodrine is caused by an increase in cardiac output. In 5 women in premature labor, the indicator dilution technique was used to check the increase in cardiac output. Arterial pressure, amniotic pressure, and heart rate were recorded electronically. The systolic blood pressure increased 12 per cent during ritodrine infusion, while the diastolic pressure decreased 10 per cent. The mean blood pressure remained stable, but the pulse pressure increased significantly at 30 minutes of infusion. A consistent increase in cardiac output was found which reached the highest value, 56 per cent over the control, at 40 minutes. There was a slight decrease in cardiac output to 35 per cent above control at 60 minutes of infusion, because of reduced venous return attributed to inhibition of uterine contractility. The significance of these findings is discussed. |
doi_str_mv | 10.1016/0002-9378(74)90660-7 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_82336639</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0002937874906607</els_id><sourcerecordid>82336639</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-69010d2ea028ceef197862798aebf4ef9b8c76d484d46d356e744547e3b1be763</originalsourceid><addsrcrecordid>eNp9kFtLxDAQhYMo67r6DxT6JPpQTZo0FxBBFm-w4Is-hzSZSqQ3k1Tw39u6i48-zQznnBnmQ-iU4CuCCb_GGBe5okJeCHapMOc4F3toSbASOZdc7qPln-UQHcX4MY-FKhZowUiJGaNLdLM2wXljs35Mw5gyNwbfvWfBp95NHWQpgEktdCnzXTYEaE0aA2SNqfpwjA5q00Q42dUVenu4f10_5ZuXx-f13Sa3tBQp5woT7AowuJAWoCZKSF4IJQ1UNYNaVdIK7phkjnFHSw6CsZIJoBWpQHC6QufbvUPoP0eISbc-Wmga00E_Ri0LSjmnajKyrdGGPsYAtR6Cb0341gTrGZqeEeiZiBZM_0LTYoqd7faPVQvuL7SjNOm3Wx2mJ788BB2th86C8wFs0q73_x_4AQGPex0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>82336639</pqid></control><display><type>article</type><title>Cardiac output during ritodrine treatment in premature labor</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bieniarz, Joseph ; Ivankovich, Anthony ; Scommegna, Antonio</creator><creatorcontrib>Bieniarz, Joseph ; Ivankovich, Anthony ; Scommegna, Antonio</creatorcontrib><description>Unlike other β-mimetic drugs, ritodrine hydrochloride is able to inhibit uterine contractility in premature labor without producing hypotension. Based on previous studies, we have postulated that this homeostatic effect of ritodrine is caused by an increase in cardiac output. In 5 women in premature labor, the indicator dilution technique was used to check the increase in cardiac output. Arterial pressure, amniotic pressure, and heart rate were recorded electronically. The systolic blood pressure increased 12 per cent during ritodrine infusion, while the diastolic pressure decreased 10 per cent. The mean blood pressure remained stable, but the pulse pressure increased significantly at 30 minutes of infusion. A consistent increase in cardiac output was found which reached the highest value, 56 per cent over the control, at 40 minutes. There was a slight decrease in cardiac output to 35 per cent above control at 60 minutes of infusion, because of reduced venous return attributed to inhibition of uterine contractility. The significance of these findings is discussed.</description><identifier>ISSN: 0002-9378</identifier><identifier>EISSN: 1097-6868</identifier><identifier>DOI: 10.1016/0002-9378(74)90660-7</identifier><identifier>PMID: 4150443</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adrenergic beta-Agonists - pharmacology ; Adrenergic beta-Agonists - therapeutic use ; Blood Pressure - drug effects ; Cardiac Output - drug effects ; Female ; Fetal Heart - drug effects ; Heart Rate - drug effects ; Humans ; Indicator Dilution Techniques ; Muscle Contraction - drug effects ; Obstetric Labor, Premature - drug therapy ; Phenethylamines - pharmacology ; Phenols - pharmacology ; Pregnancy ; Propanolamines - pharmacology ; Pulse - drug effects ; Uterus - drug effects ; Vascular Resistance - drug effects</subject><ispartof>American journal of obstetrics and gynecology, 1974-04, Vol.118 (7), p.910-920</ispartof><rights>1974</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-69010d2ea028ceef197862798aebf4ef9b8c76d484d46d356e744547e3b1be763</citedby><cites>FETCH-LOGICAL-c357t-69010d2ea028ceef197862798aebf4ef9b8c76d484d46d356e744547e3b1be763</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0002937874906607$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/4150443$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bieniarz, Joseph</creatorcontrib><creatorcontrib>Ivankovich, Anthony</creatorcontrib><creatorcontrib>Scommegna, Antonio</creatorcontrib><title>Cardiac output during ritodrine treatment in premature labor</title><title>American journal of obstetrics and gynecology</title><addtitle>Am J Obstet Gynecol</addtitle><description>Unlike other β-mimetic drugs, ritodrine hydrochloride is able to inhibit uterine contractility in premature labor without producing hypotension. Based on previous studies, we have postulated that this homeostatic effect of ritodrine is caused by an increase in cardiac output. In 5 women in premature labor, the indicator dilution technique was used to check the increase in cardiac output. Arterial pressure, amniotic pressure, and heart rate were recorded electronically. The systolic blood pressure increased 12 per cent during ritodrine infusion, while the diastolic pressure decreased 10 per cent. The mean blood pressure remained stable, but the pulse pressure increased significantly at 30 minutes of infusion. A consistent increase in cardiac output was found which reached the highest value, 56 per cent over the control, at 40 minutes. There was a slight decrease in cardiac output to 35 per cent above control at 60 minutes of infusion, because of reduced venous return attributed to inhibition of uterine contractility. The significance of these findings is discussed.</description><subject>Adrenergic beta-Agonists - pharmacology</subject><subject>Adrenergic beta-Agonists - therapeutic use</subject><subject>Blood Pressure - drug effects</subject><subject>Cardiac Output - drug effects</subject><subject>Female</subject><subject>Fetal Heart - drug effects</subject><subject>Heart Rate - drug effects</subject><subject>Humans</subject><subject>Indicator Dilution Techniques</subject><subject>Muscle Contraction - drug effects</subject><subject>Obstetric Labor, Premature - drug therapy</subject><subject>Phenethylamines - pharmacology</subject><subject>Phenols - pharmacology</subject><subject>Pregnancy</subject><subject>Propanolamines - pharmacology</subject><subject>Pulse - drug effects</subject><subject>Uterus - drug effects</subject><subject>Vascular Resistance - drug effects</subject><issn>0002-9378</issn><issn>1097-6868</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1974</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFtLxDAQhYMo67r6DxT6JPpQTZo0FxBBFm-w4Is-hzSZSqQ3k1Tw39u6i48-zQznnBnmQ-iU4CuCCb_GGBe5okJeCHapMOc4F3toSbASOZdc7qPln-UQHcX4MY-FKhZowUiJGaNLdLM2wXljs35Mw5gyNwbfvWfBp95NHWQpgEktdCnzXTYEaE0aA2SNqfpwjA5q00Q42dUVenu4f10_5ZuXx-f13Sa3tBQp5woT7AowuJAWoCZKSF4IJQ1UNYNaVdIK7phkjnFHSw6CsZIJoBWpQHC6QufbvUPoP0eISbc-Wmga00E_Ri0LSjmnajKyrdGGPsYAtR6Cb0341gTrGZqeEeiZiBZM_0LTYoqd7faPVQvuL7SjNOm3Wx2mJ788BB2th86C8wFs0q73_x_4AQGPex0</recordid><startdate>19740401</startdate><enddate>19740401</enddate><creator>Bieniarz, Joseph</creator><creator>Ivankovich, Anthony</creator><creator>Scommegna, Antonio</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19740401</creationdate><title>Cardiac output during ritodrine treatment in premature labor</title><author>Bieniarz, Joseph ; Ivankovich, Anthony ; Scommegna, Antonio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-69010d2ea028ceef197862798aebf4ef9b8c76d484d46d356e744547e3b1be763</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1974</creationdate><topic>Adrenergic beta-Agonists - pharmacology</topic><topic>Adrenergic beta-Agonists - therapeutic use</topic><topic>Blood Pressure - drug effects</topic><topic>Cardiac Output - drug effects</topic><topic>Female</topic><topic>Fetal Heart - drug effects</topic><topic>Heart Rate - drug effects</topic><topic>Humans</topic><topic>Indicator Dilution Techniques</topic><topic>Muscle Contraction - drug effects</topic><topic>Obstetric Labor, Premature - drug therapy</topic><topic>Phenethylamines - pharmacology</topic><topic>Phenols - pharmacology</topic><topic>Pregnancy</topic><topic>Propanolamines - pharmacology</topic><topic>Pulse - drug effects</topic><topic>Uterus - drug effects</topic><topic>Vascular Resistance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bieniarz, Joseph</creatorcontrib><creatorcontrib>Ivankovich, Anthony</creatorcontrib><creatorcontrib>Scommegna, Antonio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of obstetrics and gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bieniarz, Joseph</au><au>Ivankovich, Anthony</au><au>Scommegna, Antonio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiac output during ritodrine treatment in premature labor</atitle><jtitle>American journal of obstetrics and gynecology</jtitle><addtitle>Am J Obstet Gynecol</addtitle><date>1974-04-01</date><risdate>1974</risdate><volume>118</volume><issue>7</issue><spage>910</spage><epage>920</epage><pages>910-920</pages><issn>0002-9378</issn><eissn>1097-6868</eissn><abstract>Unlike other β-mimetic drugs, ritodrine hydrochloride is able to inhibit uterine contractility in premature labor without producing hypotension. Based on previous studies, we have postulated that this homeostatic effect of ritodrine is caused by an increase in cardiac output. In 5 women in premature labor, the indicator dilution technique was used to check the increase in cardiac output. Arterial pressure, amniotic pressure, and heart rate were recorded electronically. The systolic blood pressure increased 12 per cent during ritodrine infusion, while the diastolic pressure decreased 10 per cent. The mean blood pressure remained stable, but the pulse pressure increased significantly at 30 minutes of infusion. A consistent increase in cardiac output was found which reached the highest value, 56 per cent over the control, at 40 minutes. There was a slight decrease in cardiac output to 35 per cent above control at 60 minutes of infusion, because of reduced venous return attributed to inhibition of uterine contractility. The significance of these findings is discussed.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>4150443</pmid><doi>10.1016/0002-9378(74)90660-7</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9378 |
ispartof | American journal of obstetrics and gynecology, 1974-04, Vol.118 (7), p.910-920 |
issn | 0002-9378 1097-6868 |
language | eng |
recordid | cdi_proquest_miscellaneous_82336639 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adrenergic beta-Agonists - pharmacology Adrenergic beta-Agonists - therapeutic use Blood Pressure - drug effects Cardiac Output - drug effects Female Fetal Heart - drug effects Heart Rate - drug effects Humans Indicator Dilution Techniques Muscle Contraction - drug effects Obstetric Labor, Premature - drug therapy Phenethylamines - pharmacology Phenols - pharmacology Pregnancy Propanolamines - pharmacology Pulse - drug effects Uterus - drug effects Vascular Resistance - drug effects |
title | Cardiac output during ritodrine treatment in premature labor |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T19%3A52%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiac%20output%20during%20ritodrine%20treatment%20in%20premature%20labor&rft.jtitle=American%20journal%20of%20obstetrics%20and%20gynecology&rft.au=Bieniarz,%20Joseph&rft.date=1974-04-01&rft.volume=118&rft.issue=7&rft.spage=910&rft.epage=920&rft.pages=910-920&rft.issn=0002-9378&rft.eissn=1097-6868&rft_id=info:doi/10.1016/0002-9378(74)90660-7&rft_dat=%3Cproquest_cross%3E82336639%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=82336639&rft_id=info:pmid/4150443&rft_els_id=0002937874906607&rfr_iscdi=true |